NURE vs VXUS
Nuveen Short-Term REIT ETF vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. VXUS delivered stronger 1-year returns. VXUS offers more diversification with 7861 holdings.
Side-by-Side Comparison
| Metric | NURE | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 0.36% | 0.05% | |
| AUM | $36M | $156.5B | |
| Dividend Yield | 4.02% | 2.60% | |
| Holdings | 32 | 8,747 | |
| YTD Return | +12.18% | +15.00% | |
| 1Y Return | +13.90% | +26.87% | |
| 3Y Return (annualized) | +6.20% | +19.79% | |
| 5Y Return (annualized) | +0.52% | +9.26% | |
| Volatility (annualized) | 18.3% | 15.1% | |
| Max Drawdown | -46.0% | -39.9% | |
| Fund Family | Nuveen | Vanguard (US) | |
| Category | Equity | Equity | |
| Inception | Dec 19, 2016 | Jan 26, 2011 |
NURE vs VXUS Performance
Nuveen Short-Term REIT ETF (NURE) is a ETF from Nuveen and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year NURE returned +13.90% while VXUS returned +26.87%. Year to date, NURE is up 12.18% versus a gain of 15.00% for VXUS.
Over three years, NURE compounded at +6.20% per year against +19.79% for VXUS; over five years the annualized figures are +0.52% and +9.26% respectively. Across the full 10-year window we track, NURE has the edge at +5.80% annualized vs +4.88%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
NURE has been the more volatile fund, with annualized monthly volatility of 18.3% compared with 15.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -46.0% for NURE and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.70. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
NURE charges 0.36% per year while VXUS charges 0.05%. On a $10,000 position that is $36 vs $5 annually, a gap of $31 per year that compounds over a long holding period. On income, NURE currently yields 4.02% against 2.60% for VXUS.
Holdings Overlap
NURE and VXUS share 0 holdings out of 7889 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, NURE or VXUS?
NURE has an expense ratio of 0.36% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $31 per year of difference.
Which performed better, NURE or VXUS?
Over the past year NURE returned +13.90% vs +26.87% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (10 years), NURE annualized +5.80% vs +4.88% for VXUS. Past performance does not guarantee future results.
Which is riskier, NURE or VXUS?
NURE has been the more volatile fund at 18.3% annualized versus 15.1% for VXUS. Worst drawdown: NURE -46.0% vs VXUS -39.9%.
Should I hold both NURE and VXUS?
NURE and VXUS have a monthly-return correlation of 0.70, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between NURE and VXUS?
NURE and VXUS share 0 common holdings with a 0.0% weight overlap. Combined, they hold 7889 unique securities.
Which pays a higher dividend, NURE or VXUS?
NURE yields 4.02% while VXUS yields 2.60%, so NURE currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.